2005
2005 Press Releases
Exactech Q3 Revenue Up 10% to $21.5M; Net Income $1.7M or $0.15 EPS
Gainesville, FL, October 26, 2005 -- Exactech, Inc. (Nasdaq: EXAC) announced today that revenue for the third quarter of 2005 increased 10% to $21.5 million from $19.5 million in the third quarter of 2004. Diluted earnings per share for the quarter were $0.15 on net income of $1.73 million compared to diluted earnings per share of $0.14 on net income of $1.68 million.
Exactech Announces FDA Clearance of Connexion GXL Enhanced Polyethylene Hip Acetabular Liner
Gainesville, FL, October 11, 2005 -- Exactech (Nasdaq: EXAC), a developer and producer of bone and joint restoration products including orthopaedic implants and biologic materials, announced today that the company’s new Connexion™ GXL enhanced polyethylene acetabular liners for its AcuMatch® A-Series system has received 510(k) clearance from the U.S. Food and Drug Administration. The product launch is underway and will continue for the next several months.
Exactech Names Michael Simpson Vice President of Regulatory and Clinical Affairs
Gainesville, FL, September 26, 2005 -- Exactech (Nasdaq: EXAC), a developer and producer of bone and joint restoration products including orthopaedic implants and biologic materials, announced today the appointment of Michael Simpson as vice president of regulatory and clinical affairs.
Exactech Q2 Revenue Up 17% to $23.9M; Net Income $1.9M or $0.16 EPS
Gainesville, FL, July 26, 2005 -- Exactech, Inc. (NASDAQ: EXAC) announced today that revenue for the second quarter of 2005 increased 17% to $23.9 million from $20.4 million in the second quarter of 2004. Diluted earnings per share for the quarter were $0.16 based on net income of $1.9 million, which was equivalent to the second quarter of 2004.
